N/A
N=202
Affective Social Buffering
Social Stress · Adolescent Behavior
Bottom Line
View on ClinicalTrials.gov: NCT04312945 ↗Enrolled (actual)
202
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Cortisol AUCi — -93.6397; -68.0959; -106.9105 (ug/dL)*minutes
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Questionnaires (Other); MRI (Other)
- Age
- Pediatric · 11+ yrs
- Sex
- All
- Sponsor
- University of Minnesota
- Primary completion
- Feb 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cortisol AUCi |
-93.6397; -68.0959; -106.9105 | — |
| PRIMARY Change Heart Rate Response |
.543; .707; 1.343 | — |
| PRIMARY Left Amygdala: Task-related Brain Activity During Hariri Task |
0.231; 0.245; 0.232 | — |
| PRIMARY Left Amygdala: Task-related Brain Activity During IAPS GoNoGo Task |
0.28073; .29334; .29397 | — |
| PRIMARY Right Amygdala: Task-related Brain Activity During Hariri Task |
0.275; 0.273; 0.297 | — |
| PRIMARY Right Amygdala: Task-related Brain Activity During IAPS GoNoGoTask |
0.30121; 0.29021; 0.33038 | — |
| PRIMARY Left Insula: Task-related Brain Activity During Hariri Task |
-0.008; 0.0007; -0.018 | — |
| PRIMARY Left Insula: Task-related Brain Activity During IAPS GoNoGo Task |
.01627; .02078; .00809 | — |
| PRIMARY Right Insula: Task-related Brain Activity During Hariri Task |
-0.012; 0.0004; -0.017 | — |
| PRIMARY Right Insula: Task-related Brain Activity During IAPS GoNoGo Task |
.01504; .01356; -0.00077 | — |
| PRIMARY Dorsomedial Prefrontal Cortex (dmPFC): Task-related Brain Activity During Hariri Task |
0.048; 0.093; 0.108 | — |
| PRIMARY Dorsomedial Prefrontal Cortex (dmPFC): Task-related Brain Activity During IAPS GoNoGo Task |
.02224; .02385; .00827 | — |
| PRIMARY Amygdala-vmPFC: Psychophysiological Interaction (PPI) Functional Connectivity During Hariri Task |
-0.033; -0.033; 0.116 | — |
| PRIMARY Amygdala-vmPFC: Psychophysiological Interaction (PPI) Functional Connectivity During IAPS GoNoGo Task |
-0.11810; .01399; -0.01128 | — |
| PRIMARY Amygdala-dmPFC: Psychophysiological Interaction (PPI) Functional Connectivity During Hariri Task |
0.055; 0.127; 0.072 | — |
| PRIMARY Amygdala-dmPFC: Psychophysiological Interaction (PPI) Functional Connectivity During IAPS GoNoGo Task |
.01220; .008081; .04997 | — |
| PRIMARY Change in EDA During Hariri Task |
.001569; .000659; -0.01369 | — |
| PRIMARY Change in EDA During IAPS GoNoGo Task |
.002348; .003808; .000465 | — |
| PRIMARY EDA at Rest |
.0269; .0273; .0287 | — |
| SECONDARY Change in Self Report of Stress |
0.0000; .4500; .3305 | — |
| SECONDARY Change in Accuracy During Hariri Task |
-25.27; -25.37; -25.31 | — |
| SECONDARY Change in Accuracy During IAPS GoNoGo Task |
-2.01; -0.86; -2.50 | — |
Summary
The purpose of this experiment is to determine the mechanisms through which parental buffering of stress physiology during affective stimulus presentation diminishes with pubertal development and whether this diminution of effectiveness extends to social buffering by peers (best friends), in comparison to a lack of social partners.
Eligibility Criteria
Inclusion Criteria
- sufficient vision to complete assent and study procedures
- sufficient hearing to complete assent and study procedures
- sufficient language skills to provide verbal and written assent
Exclusion Criteria
- Premature birth (less than 37 weeks)
- congenital and/or chromosomal disorders (e.g. cerebral palsy, FAS, mental retardation, Turner Syndrome, Down Syndrome, Fragile X)
- Autism Spectrum Disorders
- history of serious medical illness (e.g., cancer, organ transplant)
- youth taking systemic glucocorticoids
- youth taking beta-adrenergic medications
- diagnoses of psychiatric illness, seizure disorder or other neurological disorders
- contraindications for MRI (implanted medical device; presence of non-removal metal in or on the body, including piercings, orthodontic braces or certain permanent retainers)
- known pregnancy
- tattoos
- history of significant claustrophobia
Data sourced from ClinicalTrials.gov (NCT04312945). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.